- Home
- FLGT vs BUI Comparison
FLGT vs BUI Comparison
Compare FLGT & BUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLGT
- BUI
- Stock Information
- Founded
- FLGT 2011
- BUI 2011
- Country
- FLGT United States
- BUI United States
- Employees
- FLGT N/A
- BUI N/A
- Industry
- FLGT Medical Specialities
- BUI Trusts Except Educational Religious and Charitable
- Sector
- FLGT Health Care
- BUI Finance
- Exchange
- FLGT Nasdaq
- BUI Nasdaq
- Market Cap
- FLGT 697.3M
- BUI 589.4M
- IPO Year
- FLGT 2016
- BUI N/A
- Fundamental
- Price
- FLGT $22.36
- BUI $26.06
- Analyst Decision
- FLGT Buy
- BUI
- Analyst Count
- FLGT 3
- BUI 0
- Target Price
- FLGT $25.33
- BUI N/A
- AVG Volume (30 Days)
- FLGT 199.8K
- BUI 59.8K
- Earning Date
- FLGT 11-07-2025
- BUI 01-01-0001
- Dividend Yield
- FLGT N/A
- BUI 6.79%
- EPS Growth
- FLGT N/A
- BUI N/A
- EPS
- FLGT N/A
- BUI 2.75
- Revenue
- FLGT $303,223,000.00
- BUI N/A
- Revenue This Year
- FLGT $15.19
- BUI N/A
- Revenue Next Year
- FLGT $10.58
- BUI N/A
- P/E Ratio
- FLGT N/A
- BUI $7.77
- Revenue Growth
- FLGT 4.31
- BUI N/A
- 52 Week Low
- FLGT $14.57
- BUI $18.73
- 52 Week High
- FLGT $24.64
- BUI $24.22
- Technical
- Relative Strength Index (RSI)
- FLGT 45.76
- BUI 40.96
- Support Level
- FLGT $22.06
- BUI $26.31
- Resistance Level
- FLGT $23.15
- BUI $26.78
- Average True Range (ATR)
- FLGT 0.71
- BUI 0.30
- MACD
- FLGT -0.12
- BUI -0.06
- Stochastic Oscillator
- FLGT 17.05
- BUI 17.22
About FLGT Fulgent Genetics Inc.
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.
About BUI BlackRock Utility Infrastructure & Power Opportunities Trust
BlackRock Utility Infrastructure & Power Opportunities Trust is a closed-end management investment company. Its investment objective is to provide total return through a combination of current income, current gains, and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities issued by companies that are engaged in the Utilities, Infrastructure and Power Opportunities business segments anywhere in the world and by employing of writing (selling) call and put options.